Cizzle Biotechnology Holdings Plc (CIZ.L)
CIZ.L Stock Price Chart
Explore Cizzle Biotechnology Holdings Plc interactive price chart. Choose custom timeframes to analyze CIZ.L price movements and trends.
CIZ.L Company Profile
Discover essential business fundamentals and corporate details for Cizzle Biotechnology Holdings Plc (CIZ.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 May 2021
Employees
4.00
CEO
Allan John Syms
Description
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
CIZ.L Financial Timeline
Browse a chronological timeline of Cizzle Biotechnology Holdings Plc corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Apr 2025
Earnings released on 30 Sept 2024
Earnings released on 27 Jun 2024
Earnings released on 29 Sept 2023
EPS came in at -£0.00.
Earnings released on 31 Dec 2022
EPS came in at -£0.00.
Earnings released on 30 Jun 2022
EPS came in at -£0.00.
Earnings released on 31 Dec 2021
EPS came in at -£0.00.
Earnings released on 30 Jun 2021
EPS came in at -£0.01.
Stock split effective on 14 May 2021
Shares were split 1:500, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2020
EPS came in at -£0.00.
CIZ.L Stock Performance
Access detailed CIZ.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.